FDA Approves First RSV Vaccine

WEDNESDAY, May 3, 2023 -- The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.
Arexvy, manufactured by GlaxoSmithKline (GSK), is expected to help...